Brief: Enovis Receives FDA Approval Of Patient Specific Instrumentation For Star® Ankle
Dec 1 (Reuters) - Enovis Corp ENOV.N :
* ENOVIS RECEIVES FDA APPROVAL OF PATIENT SPECIFIC
INSTRUMENTATION
FOR STAR® ANKLE
* ENOVIS CORP - PRODUCT IS ENTERING EARLY PRODUCT
SURVEILLANCE IN
DECEMBER WITH PLANS TO FULLY LAUNCH BY END OF MARCH 2023
Source text for Eikon: ID:nGNE4PLDRL
Further company coverage: ENOV.N
((Reuters.Briefs@thomsonreuters.com;;))
Recent news on Enovis
See all newsU.S. RESEARCH ROUNDUP-Adobe, Dell Technologies, Zscaler
Enovis Corporation reports results for the quarter ended June 30 - Earnings Summary
Enovis slightly beats Q2 sales estimates, reaffirms 2026 guidance
Brief: Enovis Q2 Adjusted EPS USD 0.9 Vs. IBES Estimate USD 0.85
Enovis Q1 sales rise 5%, beat expectations